首页 | 本学科首页   官方微博 | 高级检索  
     

帕拉米韦氯化钠注射液对流感病毒A型肺炎患儿的成本-效益分析
引用本文:刘燕汝,刘丽,孙青,李娜,周晓丹. 帕拉米韦氯化钠注射液对流感病毒A型肺炎患儿的成本-效益分析[J]. 现代生物医学进展, 2021, 0(4): 678-682
作者姓名:刘燕汝  刘丽  孙青  李娜  周晓丹
作者单位:西安交通大学附属第一医院财务科 陕西 西安 710061;西安交通大学附属第一医院药学部 陕西 西安 710061;西安交通大学附属第一医院小儿科 陕西 西安 710061;西安交通大学附属第一医院检验科 陕西 西安 710061;西安交通大学第一附属医院东院呼吸内科 陕西 西安 710089
基金项目:国家卫生计生委资助项目(CHEA1314060604)
摘    要:目的:探讨帕拉米韦氯化钠注射液对流感病毒A型肺炎患儿的成本-效益.方法:选择我院2015年1月至2018年12月收治的96例流感病毒A型肺炎患儿,根据随机数字表法,将96例患儿分为A组及B组,每组48例,A组患儿给予磷酸奥司他韦颗粒,B组患儿给予帕拉米韦氯化钠注射液,对比两组患儿的治疗效果、临床症状消失时间、住院时间、...

关 键 词:帕拉米韦氯化钠注射液  磷酸奥司他韦  流感病毒A型肺炎  成本-效益  不良反应
收稿时间:2020-05-06
修稿时间:2020-05-30

The Cost-benefit Analysis of Peramivir Sodium Chloride Injection in Children with Influenza Virus Type A Pneumonia
Affiliation:(Department of Finance,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi,710061,China;Department of Pharmacy,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi,710061,China;Department of Pediatrics,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi,710061,China;Department of Laboratory Medicine,First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi,710061,China;Department of Respiratory Medicine,East Hospital,First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi,710089,China)
Abstract:ABSTRACT Objective: To investigate the cost-benefit analysis of peramivir sodium chloride injection in children with influenza virus type A pneumonia. Methods: 96 children with influenza virus A pneumonia admitted to our hospital from January 2015 to December 2018 were selected, who were divided into two groups according to the random number table method, each group had 48 cases, group A were given Oseltamivir phosphate granules, group B were given Peramivir sodium chloride injection, the treatment effect, clinical symptoms disappearance time, stay length , medication cost, cost-benefit in two groups were compared, the blood routine and liver and kidney function before and after treatment were compared in two groups, and the incidence of adverse reactions was compared between the two groups. Results: The effective rate of treatment in group B was significantly higher than that in group A (P<0.05). The average drug cost of group A was significantly lower than that of group B(P<0.05), and the cost-benefit of group A was lower than that of group B(P<0.05). Compared with before treatment, the total number of neutrophils was significantly increased, and the total number of white blood cells and lymphocytes were significantly decreased in two groups after treatment(P<0.05). Before and after treatment, there were no statistical significance in blood routine indexes of two groups (P>0.05). Before and after treatment, there was no statistical significance in liver and kidney function of two groups(P>0.05). The incidence of adverse reactions in group B was higher than that in group A, but the comparison between groups was not statistically significant(P>0.05). Conclusion: Compared with Oseltamivir phosphate, Peramivir sodium chloride injection has better efficacy in the treatment of children with influenza virus type A pneumonia, while the cost-benefit was low, and medication could be selected according to the actual situation of children.
Keywords:Peramivir sodium chloride injection   Oseltamivir phosphate   Influenza virus A pneumonia   Cost-effectiveness   Adverse reactions
本文献已被 维普 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号